2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theSickle Cell Disease Treatment Market from 2025 to 2034?

The sickle cell disease treatment market is predicted to experience growth, spurred on by the escalating need for blood transfusions. These medical procedures, which involve the transferral of blood or blood products from a donor to a recipient, are integral to the management of sickle cell disease. These transfusions enhance the oxygen-carrying ability of the blood and alleviate the challenges tied to vaso-occlusion. For example, Mid-Atlantic Long-Term Care, a specialist 24-hour triage on-call service based in the US, noted in January 2022 that the US daily requirement was around 29,000 units of red blood cells, 5,000 units of platelets, and 6,500 units of plasma. Hence, the burgeoning necessity for blood transfusions is a key driver for the expansion of the sickle cell disease treatment market.

Sickle Cell Disease Treatment Market Driver: Market Growth Energised by Rising Blood and Bone Marrow Transplants

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13048&type=smp

How Has the Sickle Cell Disease Treatment Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

The market for sickle cell disease treatment has seen rapid expansion in recent years. The market is projected to increase from $2.95 billion in 2024 to $3.54 billion in 2025, showcasing a compound annual growth rate (CAGR) of 19.7%. The significant growth in the past can be credited to improved understanding of the disease, blood transfusion procedures, pain management techniques, and the use of hydroxyurea therapy.

Expectations are high for a swift expansion of the sickle cell disease treatment market in the upcoming years. Projections indicate that it will surge to a whopping $6.8 billion in 2029, boasting a compound annual growth rate (CAGR) of 17.7%. This anticipated growth during the forecast period can be ascribed to innovative strategies such as gene editing and gene therapy, the development of new drugs, the utilization of telemedicine and remote monitoring, as well as global health initiatives. The forecast period also shows major tendencies towards curative therapies, alternative pain management, global partnerships, and a significant emphasis on patient advocacy and engagement.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13048

How Are Market Trends and Innovations Revolutionizing theSickle Cell Disease Treatment Industry in Recent Times?

The primary players in the sickle cell disease treatment market are concentrating their efforts on developing innovative oral suspension drugs. Their goal for this development is to enhance drug effectiveness, raise patient adherence, and provide a wider range of treatment options, particularly for elderly and pediatric patients. Oral suspension drugs are liquid medicines containing solid particles suspended in the liquid, intended to make swallowing easier for patients, especially kids and those who have difficulty with pill intake. Take for instance, the pharmaceutical manufacturing company based in India, Akums Drugs and Pharmaceuticals Ltd, which in March 2024 unveiled a room temperature stable version of Hydroxyurea oral suspension. This treatment for SCD is not only affordable and stable at room temperature, but it also aims to increase availability in India. As it’s priced less than 1% of foreign alternatives, it ensures accurate dosage through oral syringes which benefits all age groups without needing cold storage.

Which Key Market Players Are Shaping the Future and Growth of theSickle Cell Disease Treatment Market?

Major companies operating in the sickle cell disease treatment market are Sun Pharmaceutical Industries Ltd., Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Silver Lake Research Corporation0.45, Global Blood Therapeutics Inc., Acceleron Pharma Inc., Sangamo Therapeutics Inc., Medunik USA Inc., Zydus Cadila Healthcare Ltd., Graphite Bio Inc., Addmedica, Emmaus Medical Inc., Bluebird bio Inc., CRISPR Therapeutics AG, GlycoMimetics Inc., Arena Pharmaceuticals Inc., Mast Therapeutics Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report

What Are the Core Segments of the Sickle Cell Disease Treatment Market, and How Do They Contribute to Growth?

The sickle cell disease treatment market covered in this report is segmented –

1) By Treatment Modality: Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant

2) By Disease Type: Sickle Cell Anemia, Hemoglobin Sickle C Disease (HbSC), Other Disease Types

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Blood Transfusion: Regular Blood Transfusion, Exchange Transfusion

2) By Pharmacotherapy: Hydroxyurea, L-Glutamine, Voxelotor, Crizanlizumab

3) By Bone Marrow Transplant: Allogeneic Transplant, Autologous Transplant

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13048&type=smp

What Regions Are Dominating the Sickle Cell Disease Treatment Market Growth?

North America was the largest region in the sickle cell disease treatment market in 2024. The regions covered in sickle cell disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Sickle Cell Disease Treatment Market 2025, By The Business Research Company:

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Blood Collection Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report

Blood Culture Tests Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: